171 related articles for article (PubMed ID: 14989427)
1. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
Bresnihan B
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
[TBL] [Abstract][Full Text] [Related]
2. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
Furst DE
Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
4. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
5. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis.
Bresnihan B; Cobby M
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092
[TBL] [Abstract][Full Text] [Related]
6. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].
Fiocco U; Vezzù M; Cozzi L; Todesco S
Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
[TBL] [Abstract][Full Text] [Related]
8. Anakinra: a review of its use in the management of rheumatoid arthritis.
Waugh J; Perry CM
BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
[TBL] [Abstract][Full Text] [Related]
9. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W; Jobanputra P; Barton P; Burls A
Health Technol Assess; 2004 May; 8(18):iii-iv, ix-x, 1-105. PubMed ID: 15130461
[TBL] [Abstract][Full Text] [Related]
10. [Interleukin-1 receptor antagonist anakinra (Kineret) for treatment of rheumatic arthritis].
Rubbert-Roth A; Perniok A
Z Rheumatol; 2003 Aug; 62(4):367-77. PubMed ID: 12928941
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G; Bresnihan B; Bear MB; McCabe D;
Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
[TBL] [Abstract][Full Text] [Related]
12. Bringing the clinical experience with anakinra to the patient.
Cohen SB; Rubbert A
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii36-40. PubMed ID: 12817094
[TBL] [Abstract][Full Text] [Related]
13. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
14. Anakinra treatment of patients with rheumatoid arthritis.
Calabrese LH
Ann Pharmacother; 2002; 36(7-8):1204-9. PubMed ID: 12086555
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
Bresnihan B
Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
[TBL] [Abstract][Full Text] [Related]
16. Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.
Schiff MH
Drugs; 2004; 64(22):2493-501. PubMed ID: 15516150
[TBL] [Abstract][Full Text] [Related]
17. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis.
Kavanaugh A
Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
[TBL] [Abstract][Full Text] [Related]
19. Anakinra.
Cvetkovic RS; Keating G
BioDrugs; 2002; 16(4):303-11; discussion 313-4. PubMed ID: 12196041
[TBL] [Abstract][Full Text] [Related]
20. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
